Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clive P Page

Showing results (1-10 of 139) with videos related to

Pageof 14
Sort By:
Pulmonary Pharmacology & Therapeutics|April 13, 2010
Doxofylline: a "novofylline"Clive P Page
International Archives of Allergy and Immunology|December 23, 2014
Phosphodiesterase inhibitors for the treatment of asthma and chronic obstructive pulmonary diseaseClive P Page
Current Opinion in Pharmacology|May 22, 2002
Pharmacology of airway irritabilityDomenico Spina, Clive P Page
Clinical Reviews in Allergy & Immunology|November 7, 2006
Beta2-agonists and bronchial hyperresponsivenessClive P Page, Domenico Spina
Nature Reviews. Drug Discovery|July 18, 2002
Novel drug development opportunities for heparinRebecca Lever, Clive P Page
Current Opinion in Pharmacology|April 14, 2012
Selective PDE inhibitors as novel treatments for respiratory diseasesClive P Page, Domenico Spina
Trends in Pharmacological Sciences|July 18, 2002
Asthma -- a need for a rethink?Domenico Spina, Clive P Page
Handbook of Experimental Pharmacology|May 9, 2012
Non-anticoagulant effects of heparin: an overviewRebecca Lever, Clive P Page
Expert Opinion on Investigational Drugs|August 19, 2006
Roflumilast: a phosphodiesterase-4 inhibitor for the treatment of respiratory diseaseVictoria Boswell-Smith, Clive P Page
Minerva Medica|July 8, 2021
Novel pharmacological therapies for the treatment of bronchial asthmaRichard T Amison, Clive P Page
Pageof 14

Showing results (1-10 of 139) with videos related to

Sort By:
Pageof 14
Pulmonary Pharmacology & Therapeutics|April 13, 2010
Doxofylline: a "novofylline"Clive P Page
International Archives of Allergy and Immunology|December 23, 2014
Phosphodiesterase inhibitors for the treatment of asthma and chronic obstructive pulmonary diseaseClive P Page
Current Opinion in Pharmacology|May 22, 2002
Pharmacology of airway irritabilityDomenico Spina, Clive P Page
Clinical Reviews in Allergy & Immunology|November 7, 2006
Beta2-agonists and bronchial hyperresponsivenessClive P Page, Domenico Spina
Nature Reviews. Drug Discovery|July 18, 2002
Novel drug development opportunities for heparinRebecca Lever, Clive P Page
Current Opinion in Pharmacology|April 14, 2012
Selective PDE inhibitors as novel treatments for respiratory diseasesClive P Page, Domenico Spina
Trends in Pharmacological Sciences|July 18, 2002
Asthma -- a need for a rethink?Domenico Spina, Clive P Page
Handbook of Experimental Pharmacology|May 9, 2012
Non-anticoagulant effects of heparin: an overviewRebecca Lever, Clive P Page
Expert Opinion on Investigational Drugs|August 19, 2006
Roflumilast: a phosphodiesterase-4 inhibitor for the treatment of respiratory diseaseVictoria Boswell-Smith, Clive P Page
Minerva Medica|July 8, 2021
Novel pharmacological therapies for the treatment of bronchial asthmaRichard T Amison, Clive P Page
Pageof 14